Our Mission
To improve the lives of patients affected by transthyretin amyloidoses through innovative therapeutic approaches.
Polyneuropathy and CNS Angiopathy
Oculopathy
Cardiomyopathy
Our News
What is happening in our universe.
BSIM at J.P. Morgan week
The 6th edition of The Meeting of Young Researchers in Computational Structural Biology (EJIBCE), sponsored by BSIM Therapeutics, took place at the Faculty of Sciences, University of Lisbon, on December 20, 2019.
BSIM Therapeutics at Lisbon Investor Conference
BSIM Therapeutics’ Research, Development and Innovation (RDI) system has been certified through the NP 4457:2007 standard.
By continuing to browse the site, you expressly agree that cookies will be stored on your computer to help measure statistics of visits and improve the quality of the contents offered.Learn more
